Trade Summary

4 months ago, Leftwich Scott, serving as Dir at Calidi Biotherapeutics, Inc. (CLDI), purchased 125,000 shares at $2.00 per share, for a total transaction value of $250,000.00. Following this transaction, Leftwich Scott now holds 146,631 shares of CLDI.

This purchase represents a 578.00% increase in Leftwich Scott's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, August 21, 2025 and publicly disclosed via SEC Form 4 filing on Monday, August 25, 2025, 4 days after the trade was made.

Calidi Biotherapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.